BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1683150)

  • 1. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
    Taha AS; Capell HA; Sturrock RD; Russell RI
    Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs.
    Taha AS; Sturrock RD; Russell RI
    Am J Gastroenterol; 1992 Dec; 87(12):1732-5. PubMed ID: 1360191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of peptic ulcer in rheumatoid arthritis.
    Tuteja AK; Malviya AN; Bannerjee S; Singh RR; Anand BS
    J Assoc Physicians India; 1991 Jul; 39(7):521-2. PubMed ID: 1800492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 8. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Disease-modifying" drugs in rheumatoid arthritis.
    Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
    [No Abstract]   [Full Text] [Related]  

  • 10. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Earlier intervention with second line therapies.
    Ward JR
    J Rheumatol Suppl; 1990 Nov; 25():18-23. PubMed ID: 1980313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
    Levine LR; Cloud ML; Enas NH
    Arch Intern Med; 1993 Nov; 153(21):2449-54. PubMed ID: 8215749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Digestive hemorrhage following gastroduodenal ulcers caused by non-steroidal anti-inflammatory agents].
    Raoul JL; Emery P; Bretagne JF; Chaperon J; Bansard JY; Siproudhis L; Gosselin M
    Gastroenterol Clin Biol; 1991; 15(12):950-5. PubMed ID: 1783251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 19. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 20. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
    Pincus T; Marcum SB; Callahan LF
    J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.